Lukas Utiger is a life science consultant and owner of Utiger Life Science Consulting.
With over two decades of experience in the life science industry, he provides in-depth insight and expertise in the biopharmaceutical manufacturing industry.
He joined as a member of the Abzena Board in 2022.
Lukas has held numerous positions across the biopharmaceutical services industry having acted as Group VP Asian Strategy, Pharma Service Group at Thermo Fisher Scientific, and as Division President Drug Product and Pharma Development Service North America at Patheon. In these roles, he applied the knowledge he had gained from his past 20 years at Lonza, where he had progressed from Project Manager R&D to COO and President of Lonza Bioscience.
Lukas holds a degree in Chemical Engineering from ETH Zürich, Switzerland, and a Ph.D. in Chemical Engineering from Imperial College London, UK.